Latest stories on DYN
Dyne Therapeutics GAAP EPS of -$1.08 misses by $0.33
Seeking Alpha34 · bearishearnings
Dyne Therapeutics, Inc. (DYN) files 8-K
SEC 8-K50 · neutralgeneral
Dyne Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Business Insider73 · bullishproduct/pr
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | DYN Stock News
StockTitan50 · neutralgeneral
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
Dyne a new overweight at Cantor on platform for neuromuscular disorders
Seeking Alpha63 · neutralanalyst
Dyne Therapeutics, Inc. (DYN) files 8-K
SEC 8-K50 · neutralgeneral
Dyne Therapeutics shares slide after pricing $375 million public offering (NASDAQ:DYN)
InvestorsHub24 · bearishgeneral
Dyne Therapeutics shares slide after pricing $375 million public offering (NASDAQ:DYN)
Yahoo Finance24 · bearishgeneral
Why is Dyne Therapeutics stock sliding today?
Investing.com Markets34 · bearishgeneral
Dyne Therapeutics stock falls 9% after pricing stock offering
Investing.com Markets24 · bearishgeneral
Dyne Therapeutics Upsizes Public Offering to $375 Million—What the Fundraise Means for the Company’s Pipeline
July 22, 2026
MarketChameleon26 · bearishgeneral
Biggest stock movers Wednesday: SMCI, DYN, OKLO, and more
Seeking Alpha50 · neutralgeneral
Dyne Therapeutics prices upsized $375M public offering at $20.50 per share
Seeking Alpha24 · bearishgeneral
Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock | DYN Stock News
StockTitan24 · bearishgeneral
Why DYN Shares Are Down 10% After-Hours? Day After An FDA Win, Another Announcement Rocks Stock
Stocktwits News24 · bearishgeneral
Dyne Therapeutics launches $300M stock offering; shares fall 14% in after hours
Seeking Alpha24 · bearishgeneral
Dyne Therapeutics stock falls on $300M equity offering
Investing.com Markets24 · bearishgeneral
Dyne Therapeutics Announces Proposed Public Offering of Common Stock | DYN Stock News
StockTitan24 · bearishgeneral
Dyne Therapeutics: A Buy, With Caveats, On DMD Progress
Seeking Alpha63 · neutralproduct/pr
Dyne gains FDA acceptance of z-rostudirsen BLA for Duchenne muscular dystrophy
Seeking Alpha73 · bullishproduct/pr
Dyne Therapeutics Trades Sideways Over An FDA Hurdle. Is It Time To Take Profits?
Investors.com48 · neutralgeneral